Loading...
Multimodality treatment strategies have changed prognosis of peritoneal metastases
For a long time, treatment of peritoneal metastases (PM) was mostly palliative and thus, this status was link with “terminal status/despair”. The current multimodal treatment strategy, consisting of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), has been strenuous...
Na minha lista:
| Udgivet i: | World J Gastrointest Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4714147/ https://ncbi.nlm.nih.gov/pubmed/26798438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v8.i1.67 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|